Why the study?
TGF-beta plays a critical role in PAH pathogenesis but its precise role remains uncertain, and periostin is markedly upregulated in human PAH lungs.
Does periostin-expressing cell-specific transforming growth factor-β inhibition prevent pulmonary arterial hypertension in a hypoxia-induced mouse model?
Does periostin-expressing cell-specific transforming growth factor-β inhibition prevent pulmonary arterial hypertension in a hypoxia-induced mouse model?
Targeting TGF-β signaling specifically in periostin-expressing cells may prevent the development of pulmonary arterial hypertension by inhibiting medial thickening.
PA pressure rises after Pn-specific TGF-β receptor knockout; hypothesis-generating for cell-specific TGF-β roles in PAH.
Transforming growth factor beta (TGF-β) has been shown to play a critical role in pathogenesis of pulmonary arterial hypertension (PAH) although the precise role of TGF-β signaling remains uncertain. A recent report has shown that periostin (Pn) is one of the most upregulated proteins in human PAH lung compared with healthy lungs. We established type I TGF-β receptor knockout mice specifically with Pn expressing cell (Pn-Cre/Tgfb1fl/fl mice). Increases in PA pressure and pulmonary artery muscularization were induced by hypoxia of 10% oxygen for 4 weeks. Lung Pn expression was markedly induced by 4 week-hypoxia. Pn-Cre/Tgfb1fl/fl mice showed lower right ventricular pressure elevation, inhibition of PA medial thickening. Fluorescent co-immunostaining showed that Smad3 activation in Pn expressing cell is attenuated. These results suggest that TGF-β signaling in Pn expressing cell may have an important role in the pathogenesis of PAH by controlling medial thickening.
No takes yet. Share an insight, caveat, or question.
Seki et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: